ANKE BIO
3000098.260.36% ( +0.03 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: ANKE BIO(300009) the Revenue is 541.72 M (-13.84%);the EBIT is 191.38 M (-21.82%);the EPS is 0.1 (-16.67%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.54B13.84%
----
----
EBIT
0.19B21.82%
----
----
EPS
0.116.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf